Peer Reviewed Publication , Translational Pharmaceutics , Formulation Development , Clinical Pharmacology

Application of a Novel ‘Make and Test in Parallel’ Strategy to Investigate the Effect of Formulation on the Pharmacokinetics of GDC-0810 in Healthy Subjects

23 November 2018

GDC-0810, administered orally, was used in Phase I and II clinical studies to treat estrogen receptor-positive breast cancers. Download Quotient Sciences publication here.

23 November 2018